ExodusPoint Capital Management LP Sells 43,526 Shares of Azenta, Inc. (NASDAQ:AZTA)

ExodusPoint Capital Management LP lowered its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 39.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 66,649 shares of the company’s stock after selling 43,526 shares during the quarter. ExodusPoint Capital Management LP owned approximately 0.15% of Azenta worth $3,332,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. State Street Corp grew its position in shares of Azenta by 0.4% during the 3rd quarter. State Street Corp now owns 1,686,993 shares of the company’s stock valued at $81,718,000 after acquiring an additional 6,398 shares during the period. Conestoga Capital Advisors LLC lifted its stake in Azenta by 65.0% in the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company’s stock valued at $78,894,000 after purchasing an additional 621,830 shares during the last quarter. Schroder Investment Management Group grew its holdings in Azenta by 46.7% during the fourth quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company’s stock valued at $70,183,000 after purchasing an additional 447,292 shares during the period. Allspring Global Investments Holdings LLC increased its position in Azenta by 1.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,317,385 shares of the company’s stock worth $65,922,000 after buying an additional 18,529 shares during the last quarter. Finally, Royce & Associates LP raised its stake in shares of Azenta by 2.4% in the fourth quarter. Royce & Associates LP now owns 758,068 shares of the company’s stock valued at $37,903,000 after buying an additional 18,091 shares during the period. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Needham & Company LLC increased their price target on Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a research note on Thursday, February 6th. Stephens reiterated an “overweight” rating and set a $60.00 target price on shares of Azenta in a research report on Thursday, January 2nd. Evercore ISI boosted their price target on shares of Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research report on Thursday, February 6th. Finally, TD Cowen raised shares of Azenta to a “hold” rating in a report on Thursday, February 27th.

Azenta Stock Down 7.0 %

Shares of NASDAQ AZTA opened at $29.12 on Monday. The company has a market cap of $1.33 billion, a P/E ratio of -9.77 and a beta of 1.66. Azenta, Inc. has a 52 week low of $27.93 and a 52 week high of $63.58. The business has a 50-day simple moving average of $43.01 and a two-hundred day simple moving average of $45.73.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Equities research analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.